Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	36.57	113.96	83.44
Graham Fair Price	1.36	8.60	8.49
PEG	inf	0.00	-3.59
Price/Book	-0.73	7.05	7.10
Price/Cash Flow	171.17	-219.61	80.99
Prices/Earnings	1.45	293.06	288.87
Price/Sales	-1.69	6.41	6.52
Price/FCF	171.17	-219.61	80.99
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	0.18	0.29	0.29
Operating Margin	-42.74	0.03	0.06
ROA	-0.18	< 0.005	< 0.005
ROE	< 0.005	< 0.005	-2.15
ROIC	0.02	0.01	-37.09
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.04	0.39	-89.91
Dividends QOQ	< 0.005	< 0.005	1019.26
EBIT QOQ	-0.10	-0.40	-311.95
EPS QOQ	-0.81	0.00	inf
FCF QOQ	0.48	-1.38	188.82
Revenue QOQ	< 0.005	0.04	449.87
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	27.87	146.64	426.24
Days Sales Outstanding (DSO)	69.05	64.68	-6.33
Inventory Turnover	3.23	0.61	-81.00
Debt/Capitalization	0.56	0.55	-1.09
Quick Ratio	1.37	1.39	1.39
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	22.83	23.39	2.47
Cash	4.61	4.10	-11.07
Capex	-0.60	-0.56	7.55
Free Cash Flow	2.00	-0.75	-62.49
Revenue	24.85	25.71	3.46
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.77	1.84	4.10
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	11.90	16.82	41.34
Naive Interpretation	Member

06 - Financial Health · Weak

Rating